3 of the 18 tracked hedge funds hold BCRX (BIOCRYST PHARMACEUTICALS INC) in their latest 13F filing. Combined position: $74.3M.
| Fund | Shares | Position | This quarter |
|---|---|---|---|
| Ken Griffin (Citadel) | 6.39M | $60.9M | added |
| Jim Simons (Renaissance) | 777.0K | $7.4M | reduced |
| Ray Dalio (Bridgewater) | 638.1K | $6.1M | added |
Sold out, added to, or brand-new position — email you within minutes of the 13F filing.
← all whales · ← biggest moves this quarter
Data from SEC EDGAR quarterly 13F-HR filings. 13F filings are due 45 days after quarter end and reflect equity positions only (no shorts, no options, no non-US listings). By law they lag reality by up to 6 weeks — treat as historical, not real-time.